Home » Newsletters » BioWorld Science

BioWorld Science

May 13, 2004

View Archived Issues

Antibody against collagen IV cryptic epitope limits choroidal neovascularization in vivo

Improvement of diabetes-induced retinal vascular abnormalities by AGIX-4207

Rosiglitazone effective in post-transplant diabetes

Efficacy and safety of pregabalin as add-on therapy for epilepsy

Pain Therapeutics continues development of three drug candidates

Serono achieves R&D milestones during first quarter

New hypusine production inhibitors and their use claimed by Mondobiotech

New indole-based beta2-adrenoceptor agonists in early development at Pfizer

Pfizer presents another series of 5-HT4 agonists for GI disorders

Pfizer scientists identify novel CRTh2 antagonists

Kansas State U. researchers described inhibitors of lymphatic cholesterol absorption

Novel estrogen receptor modulators covered by Pfizer patent

AstraZeneca researchers design novel CCR3 modulators/H1 antagonists

Evista launched in Japan

Aquavan enters phase III development

Abraxane NDA accepted for filing

NDS submission for Sativex in Canada

Treatment commences in Trinam phase II study

TransMID phase III program agreed under SPA

Positive results from RW study of SPI-0211 for constipation

TTP-889 successfully completes phase I

Hemispherx Biopharma to launch African trial of Alferon LDO for HIV

QR-435 shows therapeutic effect in influenza A animal studies

IND clearance for phase III trial of Rencarex in renal cell carcinoma

Preclinical efficacy of prostaglandin analogues AL-12180 and AL-12182

Selective IP antagonists inhibit bladder hyperreflexia in conscious rats and mice

Oral ECE inhibitor shows protective effect in rat model of bladder outlet obstruction

Testosterone gel associated with enhanced sexual function

Fumaric acid ester BG-12 effective in severe psoriasis

Etanercept in psoriasis subject of various presentations at EADV Spring Symposium

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
ATNM-400 radioconjugate shows efficacy in resistant breast cancer
BioWorld Science
Although hormone receptor-positive (HR+) breast cancer accounts for over 70% of cases, 20%-30% of patients still experience relapse despite endocrine therapies...